The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin 1 receptor (TRPA1) antagonist. Particularly the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer a process for preparing such formulation and its use in treating a respiratory disorder or pain in a subject.